Case Report
Volume: 5 | Issue: 12 | Published: Dec 16, 2021 | Pages: 341 - 344 | DOI: 10.24911/ejmcr/173-1629190180
A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation
Authors: Nuno Cordeiro Raposo , Nadia Mourinho Bala , Sonia Pratas , Cristina Valadas
Article Info
Authors
Nuno Cordeiro Raposo
Assistant Physician of Endocrinology, Department of Endocrinology, Hospital Beatriz Angelo, Loures, Portugal
Nadia Mourinho Bala
Resident of Endocrinology, Department of Endocrinology, Hospital Beatriz Angelo, Loures, Portugal
Sonia Pratas
Assistant Physician of Endocrinology, Department of Endocrinology, Hospital Beatriz Angelo, Loures, Portugal
Cristina Valadas
Assistant Physician of Endocrinology, Department of Endocrinology, Hospital Beatriz Angelo, Loures, Portugal
Publication History
Received: August 17, 2021
Revised: November 29, 2021
Accepted: November 29, 2021
Published: December 16, 2021
Abstract
Background: Parathyroid carcinoma (PC) is an uncommon cause of primary hyperparathyroidism (pHPT). Mutations of the cell division cycle protein 73 homolog (CDC73) gene are associated with both sporadic and familial pHPT and PC, including hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Case Presentation: A 38-year-old man presented with severe hypercalcemia and acute renal injury due to pHPT. He had a palpable left cervical mass of 50 mm, characterized by both ultrasound and 99mTc-sestamibi scintigraphy as an enlarged hyperfunctioning parathyroid gland. Histological diagnosis after parathyroidectomy was of PC. During follow-up, patient developed metastasis of the skin, mediastinal lymph-nodes, and lungs. Even after surgical excision of all detectable metastasis parathyroid hormone (PTH) remained elevated. Genetic analysis found a germline mutation (c.766_767delGT) of the CDC73 gene, which was not previously reported in PC. Conclusion: Germline CDC73 analysis may be considered in HPT-JT syndrome, familial isolated pHPT, PC, and young individuals with pHPT.
Keywords: Parathyroid carcinoma, hyperparathyroidism, CDC73 mutation, case report, green
Pubmed Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. EJMCR. 2021; 16 (December 2021): 341-344. doi:10.24911/ejmcr/173-1629190180
Web Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. https://ejmcr.com/articles/1129 [Access: December 25, 2024]. doi:10.24911/ejmcr/173-1629190180
AMA (American Medical Association) Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. EJMCR. 2021; 16 (December 2021): 341-344. doi:10.24911/ejmcr/173-1629190180
Vancouver/ICMJE Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. EJMCR. (2021), [cited December 25, 2024]; 16 (December 2021): 341-344. doi:10.24911/ejmcr/173-1629190180
Harvard Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas (2021) A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. EJMCR, 16 (December 2021): 341-344. doi:10.24911/ejmcr/173-1629190180
Chicago Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. "A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation." 16 (2021), 341-344. doi:10.24911/ejmcr/173-1629190180
MLA (The Modern Language Association) Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas. "A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation." 16.December 2021 (2021), 341-344. Print. doi:10.24911/ejmcr/173-1629190180
APA (American Psychological Association) Style
Nuno Cordeiro Raposo, Nadia Mourinho Bala, Sonia Pratas, Cristina Valadas (2021) A case report of a patient with parathyroid carcinoma and a CDC73 germline mutation. , 16 (December 2021), 341-344. doi:10.24911/ejmcr/173-1629190180